Year: 2026
Type: article
Abstract: In this commentary, we reflect on GAVI's experience incorporating an antimicrobial resistance (AMR) criterion into the Vaccine Investment Strategy to explore how global vaccine policy can more integrate AMR objectives, and identify priority actions for maximizing the AMR impact of vaccines. This article is part of the Royal Society Science+ meeting issue 'Vaccines and antimicrobial resistance: from science to policy'.
Authors: Nidhee Jadeja, Mateusz Hasso-Agopsowicz, Marta Urrutxi Gallastegi, Maya Malarski, Michelle Jimenez, Birgitte Giersing, Marta Tufet
Institutions: Gavi, World Health Organization
Language: English
Subfield: Applied Microbiology and Biotechnology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: hybrid
OpenAlex ID: W7130503397